Log in Register
Menu

Anti-Fbxo7, Polyclonal [HLA3]

Invented by Dr Heike Laman at University of Cambridge

Info

Catalogue Number 151883
Applications IHC IP WB
Antigen/Gene or Protein Targets Fbxo7
Reactivity Human and Mouse
Relevance Recessive mutations in FBXO7/PARK15 cause an atypical EOPD. In certain cancers, the protein is highly expressed.

These cell lines all express Fbxo7: U2OS, SHSY5Y, HEK293, Jurkat, SKOV3, HeLa, Ba-F3, Nalm6, C33A, MEL, HSPCs, MEFs.
Host Rabbit
Immunogen aa 499-522 of human Fbxo7 synthetic peptide coupled to KLH
Molecular Weight (kDa) ~59/~70
Notes Staining Pattern: Nuclear and cytoplasmic, depending on stage of the cell cycle. May be aberrantly localised in pathological conditions.

This antibody is not available for licence, please refer to supplier information to find a source of the antibody.
Positive Control Any cultured cell line grown in FBS
Research Area Cell Cycle, Epigenetics & Nuclear Signalling

References: 3 entries

Burchell et al. 2013. Nat Neurosci. 16(9):1257-65. PMID: 23933751.

Meziane el et al. 2011. J Cell Sci. 124(Pt 13):2175-86. PMID: 21652635.

Laman et al. 2005. EMBO J. 24(17):3104-16. PMID: 16096642.


Add a reference

References: 3 entries

Burchell et al. 2013. Nat Neurosci. 16(9):1257-65. PMID: 23933751.

Meziane el et al. 2011. J Cell Sci. 124(Pt 13):2175-86. PMID: 21652635.

Laman et al. 2005. EMBO J. 24(17):3104-16. PMID: 16096642.


Add a reference

References: 3 entries

Burchell et al. 2013. Nat Neurosci. 16(9):1257-65. PMID: 23933751.

Meziane el et al. 2011. J Cell Sci. 124(Pt 13):2175-86. PMID: 21652635.

Laman et al. 2005. EMBO J. 24(17):3104-16. PMID: 16096642.


Add a reference


This reagent does not have any reviews at the moment.